Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

University Hospital Erlangen - DISQVER

ABSTRACT: Metagenomic analysis of microbial cell-free DNA from whole blood specimens of patients with suspected infections: performance and therapeutic impact in clinical routine

PROVIDER: PRJEB84424 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	ERR14173200.fastq.gz	Fastqsanger.gz
	ERR14173300.fastq.gz	Fastqsanger.gz
	ERR14173201.fastq.gz	Fastqsanger.gz
	ERR14173301.fastq.gz	Fastqsanger.gz
	ERR14173202.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 190

Similar Datasets

Diagnostic performance of transcriptomic signatures for the evaluation of suspected tuberculosis in routine clinical practice

Project description:Diagnostic performance of transcriptomic signatures for the evaluation of suspected tuberculosis in routine clinical practice

| PRJNA602856 | ENA

TEP With 68-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors

Project description:Evaluation of the diagnostic performance of PET / CT with 68Ga-DOTANOC in Gastroenteropancreatic Neuroendocrine Tumors with comparison with other techniques used in routine clinical practice (octreoscan ; multiphase SPECT / CT, MRI or endoscopy). Therapeutic impact and safety of PET / CT with 68Ga-DOTANOC will also be assessed. Expected results are a confirmation of the superiority of 68Ga-PET DOTANOC versus scintigraphy octreoscan , with a potential impact on the therapeutic management of patients.

| 2136662 | ecrin-mdr-crc

Project description:The diagnostic performance of metagenomics next-generation sequencing in the suspected central nervous system infections

| PRJNA1118056 | ENA

Feasibility of Quality of Life Assessment in Routine Clinical Oncology Practice at the University Hospital of Besancon

Project description:Symptoms related to the disease and/or treatment are common in cancer patients and can affect patient health-related quality of life (HRQol). Unfortunately these symptoms can be underestimated and underreported by the physician. Measure of the HRQoL has been significantly developed in clinical trials and has become a key endpoint to assess clinical benefit of new therapeutic strategies and as prognostic factor of overall survival for several cancer as in women breast cancer, glioblastomas, metastatic colorectal cancer, prostate cancer and hepatocellular carcinoma. Moreover, a recent study conducted in patients receiving routine outpatient chemotherapy for advanced solid tumors showed that clinical benefits were associated with symptom self-reporting during cancer care, including the improvement of the overall survival. The aim of the QOLIBRY project is to introduce the collection of HRQoL of cancer patients in daily clinical practice in the University Hospital of Besançon. Indeed, the goal is to make the HRQoL data accessible and exploitable in real time to physician, to help medical professionals to optimize their practices by adopting a holistic and personalized approach based on the perception of the patients of their HRQoL and symptoms.

| 2220691 | ecrin-mdr-crc

Pediatric RTIs

Project description:This series includes 278 microarrays used to detect respiratory viruses in a set of nasopharyngeal lavage specimens from children with respiratory tract infections Objective: To assess the utility of a pan-viral DNA microarray platform (Virochip) in the detection of viruses associated with pediatric respiratory tract infections. Study Design: The Virochip was compared to conventional clinical direct fluorescent antibody (DFA) and PCR-based testing for the detection of respiratory viruses in 278 consecutive nasopharyngeal aspirate samples from 222 children. Results: The Virochip was superior in performance to DFA, showing a 19% increase in the detection of 7 respiratory viruses included in standard DFA panels, and was similar to virus-specific PCR (sensitivity 85-90%, specificity 99%, PPV 94-96%, NPV 97-98%) in the detection of respiratory syncytial virus, influenza A, and rhino-/enteroviruses. The Virochip also detected viruses not routinely tested for or missed by DFA and PCR, as well as double infections and infections in critically ill patients that DFA failed to detect. Conclusions: Given its favorable sensitivity and specificity profile and greatly expanded spectrum of detection, microarray-based viral testing holds promise for clinical diagnosis of pediatric respiratory tract infections. Keywords: viral detection The series includes 278 clinical specimens

2010-05-26 | E-GEOD-10294 | biostudies-arrayexpress

C. diphtheriae

Project description:Suspected Outbreak of C. diphtheriae wound infections

| PRJEB14914 | ENA

CGH profiles of primary breast carcinomas from HBOC (Hereditary Breast and Ovarian Cancer) families

Project description:89 tumors from women that were eligible for, and subjected to, routine diagnostic testing according to the HBOC criteria but were negative for pathogenic BRCA1/2-mutations or carried an UV in either BRCA1/2 A BRCA2-classifier was built using array-CGH profiles of 28 BRCA2-mutated and 28 sporadic breast tumors. The classifier was validated on an independent group of 19 BRCA2-mutated and 19 sporadic breast tumors. Subsequently, we tested 89 breast tumors from suspected hereditary breast (and ovarian) cancer (HBOC) families, in which either no BRCA1/2 mutation or an UV had been found by routine diagnostics.

2010-07-05 | E-GEOD-22481 | biostudies-arrayexpress

Project description:Metagenomics samples from dogs with suspected flavivirus infections

| PRJNA910132 | ENA

Children's Hospital, the Second Affiliated Hospital of Shaanxi University of Chinese Medicine

Project description:we adopted DIA-MS method to profile serum proteome signatures of acute asthma children and convalescent ones. As result, we identified 747 proteins were identified in 46 serum samples and detected 37 differentially expressed proteins that could clearly separate asthmatic and healthy children.

2022-04-20 | PXD033315 |

Introduction of oncological case managers in the center of gastrointestinal tumors at the University Hospital Freiburg - An interventional study to analyse the influence on the treatment of oncological patients

Project description:Interventions: Group 1: Routine care Group 2: Patient care by case-managers; preparation of medical records with the checklist, contact with the patient before and after an initial consultation with the doctor, informative talks, contacts throughout the treatment period. Primary outcome(s): The primary objective of the study is, regarding the impact of the establishment of a case-manager on patient care to measure the a) course of treatment according to the treatment pathways (patient safety) b.) compliance with the time schedule (Patient care) c.) information of the patient (Patient-orientation) d) Satisfaction with care (Patient satisfaction) Study Design: Allocation: Randomized controlled study; Masking: Blinded (masking used); Control: active; Assignment: parallel; Study design purpose: health services research

| 2429823 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data